NTHI 8-K: Fda approval

NeOnc Technologies

Filed with the SEC on · accession 0001829126-26-012601

NTHI filed a 8-K (current report) with the SEC on Nov 18, 2026. NeOnc Technologies announced updated interim results from the Phase 2a portion of its NEO100-01 clinical study of intranasal NEO100, reporting an additional confirmed response that increased the objective response rate from 8.3% to 12.5% (3 of 24 patients) per RANO 2.0 criteria.

Summary of the filing

NeOnc Technologies announced updated interim results from the Phase 2a portion of its NEO100-01 clinical study of intranasal NEO100, reporting an additional confirmed response that increased the objective response rate from 8.3% to 12.5% (3 of 24 patients) per RANO 2.0 criteria. The company also disclosed that CEO Amir Heshmatpour purchased 30,000 shares of common stock on the open market.

Key details

Shares of common stock purchased on the open market by CEO Amir F. Heshmatpour$30K
Registrant / issuerNeOnc Technologies Holdings, Inc.
Executive chairman, president and chief executive officerAmir F. Heshmatpour

✦ Ask GOAX AI about this filing — what it means for NTHI, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NTHI?

Click here

Frequently asked questions

What did NTHI file with the SEC on Nov 18, 2026?

NTHI filed a 8-K (Fda approval). NeOnc Technologies announced updated interim results from the Phase 2a portion of its NEO100-01 clinical study of intranasal NEO100, reporting an additional confirmed response that increased the objective response rate from 8.3% to 12.5% (3 of 24 patients) per RANO 2.0 criteria. The company also disclosed that CEO Amir Heshmatpour purchased 30,000 shares of common stock on the open market.

What does a fda approval mean for NTHI stock?

For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other NTHI SEC filings

Get alerts when NTHI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days